Publicaciones en las que colabora con NURIA ERITJA SANCHEZ (19)
2022
-
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition
Scientific Reports, Vol. 12, Núm. 1
-
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
Cancers, Vol. 14, Núm. 12
2017
-
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium
Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458
-
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Autophagy, Vol. 13, Núm. 3, pp. 608-624
-
Endometrial carcinoma: Specific targeted pathways
Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 149-207
2016
-
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
Oncotarget, Vol. 7, Núm. 32, pp. 52364-52374
2013
-
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
Molecular Oncology, Vol. 7, Núm. 4, pp. 763-775
-
Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometrial cells and drives PTEN loss-induced hyperplasic growth
American Journal of Pathology, Vol. 183, Núm. 1, pp. 277-287
2011
-
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels
American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543
-
Nuclear factor-B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
Laboratory Investigation, Vol. 91, Núm. 6, pp. 859-871
2010
-
A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis
American Journal of Pathology, Vol. 176, Núm. 6, pp. 2722-2731
-
The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
European Journal of Cancer, Vol. 46, Núm. 4, pp. 836-850
2009
-
A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma
Analytical and Quantitative Cytology and Histology, Vol. 31, Núm. 4, pp. 217-226
-
CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation
American Journal of Pathology, Vol. 174, Núm. 1, pp. 287-296
-
Molecular pathology of endometrial carcinoma: Practical aspects from the diagnostic and therapeutic viewpoints
Journal of Clinical Pathology, Vol. 62, Núm. 9, pp. 777-785
2008
-
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells
Anti-Cancer Drugs, Vol. 19, Núm. 2, pp. 115-124
-
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells
Oncogene, Vol. 27, Núm. 18, pp. 2513-2524
-
Loss of heterozygosity in endometrial carcinoma
International Journal of Gynecological Pathology, Vol. 27, Núm. 3, pp. 305-317
-
Nuclear factor-κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma
Human Pathology, Vol. 39, Núm. 7, pp. 994-1001